Literature DB >> 3351865

Resolution of the nonsteroidal antiandrogen 4'-cyano-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'- (trifluoromethyl)-propionanilide and the determination of the absolute configuration of the active enantiomer.

H Tucker1, G J Chesterson.   

Abstract

The nonsteroidal antiandrogen 4'-cyano-3-[(4-fluorophenyl)sulfonyl]-2- hydroxy-2-methyl-3'-(trifluoromethyl)-propionanilide (1) (ICI 176334) has been resolved by chromatographic separation of the diastereomeric (R)-camphanyl esters of the precursor thioether 2 followed by hydrolysis and oxidation of the isolated enantiomers. In addition, an asymmetric synthesis of (S)-3-bromo-2-hydroxy-2-methylpropanoic acid (11) and subsequent conversion into the (S)-sulfone 6a has established that the more potent enantiomer of 1 has the R absolute configuration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3351865     DOI: 10.1021/jm00399a034

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Synthesis of irreversibly binding bicalutamide analogs for imaging studies.

Authors:  Vipin A Nair; Suni M Mustafa; Michael L Mohler; Jun Yang; Leonid I Kirkovsky; James T Dalton; Duane D Miller
Journal:  Tetrahedron Lett       Date:  2005-07-11       Impact factor: 2.415

Review 2.  Bicalutamide: clinical pharmacokinetics and metabolism.

Authors:  Ian D Cockshott
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Spectrophotometric estimation of bicalutamide in tablets.

Authors:  P P Sancheti; V M Vyas; Manali Shah; Poonam Karekar; Y V Pore
Journal:  Indian J Pharm Sci       Date:  2008-11       Impact factor: 0.975

4.  Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis.

Authors:  Amer Jamalpoor; Charlotte Agh van Gelder; Fjodor A Yousef Yengej; Esther A Zaal; Sante P Berlingerio; Koenraad R Veys; Carla Pou Casellas; Koen Voskuil; Khaled Essa; Carola Me Ammerlaan; Laura Rita Rega; Reini En van der Welle; Marc R Lilien; Maarten B Rookmaaker; Hans Clevers; Judith Klumperman; Elena Levtchenko; Celia R Berkers; Marianne C Verhaar; Maarten Altelaar; Rosalinde Masereeuw; Manoe J Janssen
Journal:  EMBO Mol Med       Date:  2021-06-24       Impact factor: 12.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.